Login / Signup

Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis.

Anna E SsentongoPaddy SsentongoEmily S HeilbrunnAlain LekoubouPing DuDuanping LiaoJohn S OhVernon M Chinchilli
Published in: Open heart (2020)
The present study has been registered with PROSPERO (registration ID: CRD 42020187963).
Keyphrases
  • angiotensin ii
  • coronavirus disease
  • angiotensin converting enzyme
  • sars cov
  • blood pressure
  • cardiovascular events
  • type diabetes
  • respiratory syndrome coronavirus